BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 23409771)

  • 1. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques.
    Thörnqvist S; Bentzen L; Petersen JB; Hysing LB; Muren LP
    Acta Oncol; 2011 Aug; 50(6):926-34. PubMed ID: 21767193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning.
    Tang S; Deville C; Tochner Z; Wang KK; McDonough J; Vapiwala N; Both S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1186-94. PubMed ID: 25442043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets.
    Pilskog S; Abal B; Øvrelid KS; Engeseth GM; Ytre-Hauge KS; Hysing LB
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):630-638. PubMed ID: 31759076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
    Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
    Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.
    Andersen AG; Casares-Magaz O; Muren LP; Toftegaard J; Bentzen L; Thörnqvist S; Petersen JB
    Acta Oncol; 2015; 54(9):1643-50. PubMed ID: 26203931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer.
    Thörnqvist S; Hysing LB; Zolnay AG; Söhn M; Hoogeman MS; Muren LP; Bentzen L; Heijmen BJ
    Radiother Oncol; 2013 Dec; 109(3):344-9. PubMed ID: 24183863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
    Liu F; Ahunbay E; Lawton C; Li XA
    Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.
    Cantin A; Gingras L; Lachance B; Foster W; Goudreault J; Archambault L
    Med Phys; 2015 Dec; 42(12):7011-21. PubMed ID: 26632056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
    Reddy NM; Nori D; Chang H; Lange CS; Ravi A
    Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.
    Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
    Phys Med Biol; 2017 Mar; 62(5):1644-1660. PubMed ID: 28166057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.
    Su Z; Li Z; Henderson R; Hoppe B; Nichols RC; Bryant C; Mendenhall W; Mendenhall N
    Phys Med Biol; 2019 Feb; 64(4):04NT04. PubMed ID: 30630135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.
    Casares-Magaz O; Moiseenko V; Hopper A; Pettersson NJ; Thor M; Knopp R; Deasy JO; Muren LP; Einck J
    Acta Oncol; 2017 Jun; 56(6):884-890. PubMed ID: 28401808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
    Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer?
    Góra J; Stock M; Lütgendorf-Caucig C; Georg D
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):881-8. PubMed ID: 22818417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.